These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21049069)

  • 1. Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes?
    Meindl A
    Breast Care (Basel); 2009; 4(2):93-99. PubMed ID: 21049069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
    Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
    Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for low-penetrance cancer susceptibility alleles.
    Houlston RS; Peto J
    Oncogene; 2004 Aug; 23(38):6471-6. PubMed ID: 15322517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for common genomic variants in the assessment of familial breast cancer.
    Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
    J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
    Palomba G; Loi A; Porcu E; Cossu A; Zara I; Budroni M; Dei M; Lai S; Mulas A; Olmeo N; Ionta MT; Atzori F; Cuccuru G; Pitzalis M; Zoledziewska M; Olla N; Lovicu M; Pisano M; Abecasis GR; Uda M; Tanda F; Michailidou K; Easton DF; Chanock SJ; Hoover RN; Hunter DJ; Schlessinger D; Sanna S; Crisponi L; Palmieri G
    BMC Cancer; 2015 May; 15():383. PubMed ID: 25956309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    Wendt C; Margolin S
    Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial prostate cancer.
    Giri VN; Beebe-Dimmer JL
    Semin Oncol; 2016 Oct; 43(5):560-565. PubMed ID: 27899188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
    Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
    Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and Function of Breast Cancer Susceptibility Alleles.
    Torabi Dalivandan S; Plummer J; Gayther SA
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
    Aloraifi F; Boland MR; Green AJ; Geraghty JG
    Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer susceptibility: current knowledge and implications for genetic counselling.
    Ripperger T; Gadzicki D; Meindl A; Schlegelberger B
    Eur J Hum Genet; 2009 Jun; 17(6):722-31. PubMed ID: 19092773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers.
    Milne RL; Antoniou AC
    Ann Oncol; 2011 Jan; 22 Suppl 1():i11-7. PubMed ID: 21285145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families.
    Johnson J; Healey S; Khanna KK; ; Chenevix-Trench G
    Breast Cancer Res Treat; 2011 Aug; 129(1):255-63. PubMed ID: 21533530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance.
    Skol AD; Sasaki MM; Onel K
    Breast Cancer Res; 2016 Oct; 18(1):99. PubMed ID: 27716388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
    Riedlova P; Janoutova J; Hermanova B
    Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
    Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
    Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
    Jones MR; Kamara D; Karlan BY; Pharoah PDP; Gayther SA
    Gynecol Oncol; 2017 Dec; 147(3):705-713. PubMed ID: 29054568
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.